Catastrophic expenditure on medicines in brazil

Show simple item record

dc.contributor.author Luiza, Vera Lucia
dc.contributor.author Leao Tavares, Noemia Urruth
dc.contributor.author Oliveira, Maria Auxiliadora
dc.contributor.author Dourado Arrais, Paulo Sergio
dc.contributor.author Ramos, Luiz Roberto [UNIFESP]
dc.contributor.author Dal Pizzol, Tatiane da Silva
dc.contributor.author Mengue, Sotero Serrate
dc.contributor.author Farias, Mareni Rocha
dc.contributor.author Bertoldi, Andrea Damaso
dc.date.accessioned 2019-01-21T10:29:36Z
dc.date.available 2019-01-21T10:29:36Z
dc.date.issued 2016
dc.identifier http://dx.doi.org/10.1590/s1518-8787.2016050006172
dc.identifier.citation Revista De Saude Publica. Sao paulo, v. 50, n. 2, p. 15s, 2016.
dc.identifier.issn 0034-8910
dc.identifier.uri http://repositorio.unifesp.br/handle/11600/49284
dc.description.abstract OBJECTIVE: To describe the magnitude of the expenditure on medicines in Brazil according to region, household size and composition in terms of residents in a situation of dependency. METHODS: Population-based data from the national household survey were used, with probabilistic sample, applied between September 2013 and February 2014 in urban households. The expenditure on medicines was the main outcome of interest. The prevalence and confidence intervals (95% CI) of the outcomes were stratified according to socioeconomic classification and calculated according to the region, the number of residents dependent on income, the presence of children under five years and residents in a situation of dependency by age. RESULTS: In about one of every 17 households (5.3%) catastrophic health expenditure was reported and, in 3.2%, the medicines were reported as one of the items responsible for this situation. The presence of three or more residents (3.6%) and resident in a situation of dependency (3.6%) were the ones that most reported expenditure on medicines. Southeast was the region with the lowest prevalence of expenditure on medicines. The prevalence of households with catastrophic health expenditure and on medicines in relation to the total of households showed a regressive tendency for economic classes. CONCLUSIONS: Catastrophic health expenditure was present in 5.3%, and catastrophic expenditure on medicines in 3.2% of the households. Multi-person households, presence of residents in a situation of economic dependency and belonging to the class D or E had the highest proportion of catastrophic expenditure on medicines. Although the problem is important, permeated by aspects of iniquity, Brazilian policies seem to be protecting families from catastrophic expenditure on health and on medicine. en
dc.description.sponsorship Department for Pharmaceutical Services and Strategic Health Supplies (DAF) of the Secretariat of Science, Technology and Strategic Inputs of the Brazilian Ministry of Health (SCTIE/MS) [25000.111834/2]
dc.description.sponsorship Department of Science and Technology (DECIT) of the Secretariat of Science, Technology and Strategic Inputs of the Brazilian Ministry of Health (SCTIE/MS) [25000.111834/2]
dc.format.extent 15s
dc.language.iso eng
dc.publisher Elsevier Science Bv
dc.relation.ispartof Revista De Saude Publica
dc.rights Acesso aberto
dc.subject Health Expenditure en
dc.subject Access en
dc.subject Countries en
dc.subject System en
dc.subject Care en
dc.title Catastrophic expenditure on medicines in brazil en
dc.title Gasto catastrófico com medicamentos no Brasil pt
dc.type Artigo
dc.description.affiliation Departamento de Política de Medicamentos e Assistência Farmacêutica. Escola Nacional de Saúde Pública Sérgio Arouca. Fundação Oswaldo Cruz. Rio de Janeiro, RJ, Brasil
dc.description.affiliation Departamento de Farmácia. Faculdade de Ciências da Saúde. Universidade de Brasília. Brasília, DF, Brasil
dc.description.affiliation Departamento de Farmácia. Faculdade de Farmácia, Odontologia e Enfermagem. Universidade Federal do Ceará. Fortaleza, CE, Brasil
dc.description.affiliation Departamento de Medicina Preventiva. Escola Paulista de Medicina. Universidade Federal de São Paulo. São Paulo, SP, Brasil
dc.description.affiliation Departamento de Produção e Controle de Medicamentos. Faculdade de Farmácia. Universidade Federal do Rio Grande do Sul. Porto Alegre, RS, Brasil
dc.description.affiliation Programa de Pós-Graduação em Epidemiologia. Faculdade de Medicina. Universidade Federal do Rio Grande do Sul. Porto Alegre, RS, Brasil
dc.description.affiliation Departamento de Ciências Farmacêuticas. Centro de Ciências da Saúde. Universidade Federal de Santa Catarina. Florianópolis, SC, Brasil
dc.description.affiliation Departamento de Medicina Social. Faculdade de Medicina. Universidade Federal de Pelotas. Pelotas, RS, Brasil
dc.description.affiliationUnifesp Departamento de Medicina Preventiva. Escola Paulista de Medicina. Universidade Federal de São Paulo. São Paulo, SP, Brasil
dc.description.sponsorshipID SCTIE/MS: 25000.111834/2
dc.identifier.file S0034-89102016000300302.pdf
dc.identifier.scielo S0034-89102016000300302
dc.identifier.doi 10.1590/S1518-8787.2016050006172
dc.description.source Web of Science
dc.identifier.wos WOS:000391447400012



File

File Size Format View

There are no files associated with this item.

This item appears in the following Collection(s)

Show simple item record

Search


Browse

Statistics

My Account